AN2 Historical Income Statement
| ANTX Stock | USD 2.32 0.04 1.75% |
Historical analysis of AN2 Therapeutics income statement accounts such as Interest Expense of 620.7 K, Selling General Administrative of 14 K or Selling And Marketing Expenses of 17.8 M can show how well AN2 Therapeutics performed in making a profits. Evaluating AN2 Therapeutics income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of AN2 Therapeutics's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining AN2 Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether AN2 Therapeutics is a good buy for the upcoming year.
AN2 |
About AN2 Income Statement Analysis
AN2 Therapeutics Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to AN2 Therapeutics shareholders. The income statement also shows AN2 investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
AN2 Therapeutics Income Statement Chart
AN2 Therapeutics Income Statement is one of the three primary financial statements used for reporting AN2's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of AN2 Therapeutics revenue and expense. AN2 Therapeutics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, AN2 Therapeutics' Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 620.7 K in 2024, whereas Selling General Administrative is likely to drop slightly above 14 K in 2024. Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of AN2 Therapeutics. It is also known as AN2 Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from AN2 Therapeutics' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into AN2 Therapeutics current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AN2 Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy AN2 Stock please use our How to Invest in AN2 Therapeutics guide.At this time, AN2 Therapeutics' Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to rise to about 620.7 K in 2024, whereas Selling General Administrative is likely to drop slightly above 14 K in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 69K | 1.4M | 1.6M | 1.6M | Net Interest Income | 69K | 1.4M | 1.6M | 1.6M |
AN2 Therapeutics income statement Correlations
Click cells to compare fundamentals
AN2 Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AN2 Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AN2 Therapeutics' short interest history, or implied volatility extrapolated from AN2 Therapeutics options trading.
Pair Trading with AN2 Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AN2 Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with AN2 Stock
| 0.61 | DVAX | Dynavax Technologies Financial Report 7th of May 2024 | PairCorr |
Moving against AN2 Stock
| 0.73 | HCM | HUTCHMED DRC | PairCorr |
| 0.64 | BHC | Bausch Health Companies Financial Report 2nd of May 2024 | PairCorr |
| 0.56 | EBS | Emergent Biosolutions Financial Report 14th of May 2024 | PairCorr |
| 0.51 | DRRX | Durect Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to AN2 Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AN2 Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AN2 Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AN2 Therapeutics to buy it.
The correlation of AN2 Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AN2 Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AN2 Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AN2 Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AN2 Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy AN2 Stock please use our How to Invest in AN2 Therapeutics guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for AN2 Stock analysis
When running AN2 Therapeutics' price analysis, check to measure AN2 Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AN2 Therapeutics is operating at the current time. Most of AN2 Therapeutics' value examination focuses on studying past and present price action to predict the probability of AN2 Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AN2 Therapeutics' price. Additionally, you may evaluate how the addition of AN2 Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Commodity Directory Find actively traded commodities issued by global exchanges |
Is AN2 Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AN2 Therapeutics. If investors know AN2 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AN2 Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.74) | Return On Assets (0.36) | Return On Equity (0.59) |
The market value of AN2 Therapeutics is measured differently than its book value, which is the value of AN2 that is recorded on the company's balance sheet. Investors also form their own opinion of AN2 Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is AN2 Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AN2 Therapeutics' market value can be influenced by many factors that don't directly affect AN2 Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AN2 Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AN2 Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AN2 Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.